Insulin pump therapy is independently associated with a 23% reduction in 30-day hospital readmissions among adults with type 1 diabetes compared to injectable insulin alone.
In-hospital mortality was lower in insulin pump users, with a 22% adjusted reduction in odds of death during index admission.
The 2022 Nationwide Readmissions Database provides a nationally representative insight into inpatient outcomes linked to insulin delivery modality in type 1 diabetes.
